Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,374) with videos related to
Page
of 138
Sort By:
BMC Infectious Diseases
|
April 13, 2017
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Tony Antoniou, Leah Szadkowski, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 17, 2016
A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy
Jennifer Gillis, Mona Loutfy, Ahmed M Bayoumi, et al.
HIV Clinical Trials
|
August 22, 2014
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial
Marina B Klein, Terry Lee, Marie-Josée Brouillette, et al.
Free Radical Biology & Medicine
|
March 18, 2014
Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment
Y Zhao, S Miriyala, L Miao, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 14, 2014
Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men
Julia L Marcus, Chun R Chao, Wendy A Leyden, et al.
Pharmacoepidemiology and Drug Safety
|
November 3, 2021
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design
Jim Young, Vincent Lo Re, H Nina Kim, et al.
Journal of the International Association of Providers of AIDS Care
|
December 7, 2013
Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada
Alexis K Palmer, Angela Cescon, Keith Chan, et al.
Oral Oncology
|
October 11, 2014
Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals
Daniel C Beachler, Alison G Abraham, Michael J Silverberg, et al.
The Journal of Infectious Diseases
|
September 2, 2017
Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing
Dana S Clutter, Shuntai Zhou, Vici Varghese, et al.
Scientific Reports
|
October 15, 2020
Differentiating Staphylococcus infection-associated glomerulonephritis and primary IgA nephropathy: a mass spectrometry-based exploratory study
Anjali A Satoskar, John P Shapiro, Mikayla Jones, et al.
Page
of 138
Search research articles
Search
Showing results (1121-1130 of 1,374) with videos related to
Sort By:
Page
of 138
BMC Infectious Diseases
|
April 13, 2017
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Tony Antoniou, Leah Szadkowski, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 17, 2016
A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy
Jennifer Gillis, Mona Loutfy, Ahmed M Bayoumi, et al.
HIV Clinical Trials
|
August 22, 2014
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial
Marina B Klein, Terry Lee, Marie-Josée Brouillette, et al.
Free Radical Biology & Medicine
|
March 18, 2014
Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment
Y Zhao, S Miriyala, L Miao, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 14, 2014
Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men
Julia L Marcus, Chun R Chao, Wendy A Leyden, et al.
Pharmacoepidemiology and Drug Safety
|
November 3, 2021
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design
Jim Young, Vincent Lo Re, H Nina Kim, et al.
Journal of the International Association of Providers of AIDS Care
|
December 7, 2013
Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada
Alexis K Palmer, Angela Cescon, Keith Chan, et al.
Oral Oncology
|
October 11, 2014
Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals
Daniel C Beachler, Alison G Abraham, Michael J Silverberg, et al.
The Journal of Infectious Diseases
|
September 2, 2017
Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing
Dana S Clutter, Shuntai Zhou, Vici Varghese, et al.
Scientific Reports
|
October 15, 2020
Differentiating Staphylococcus infection-associated glomerulonephritis and primary IgA nephropathy: a mass spectrometry-based exploratory study
Anjali A Satoskar, John P Shapiro, Mikayla Jones, et al.
Page
of 138